Advertisement

Topics

FDA clears Creo's Speedboat RS2 endoscopic device, CROMA platform

06:34 EDT 22 Aug 2017 | SmartBrief

The FDA gave Creo Medical Group 510(k) clearance for the Speedboat RS2 device and the CROMA platform 49 days after the compan -More

Original Article: FDA clears Creo's Speedboat RS2 endoscopic device, CROMA platform

NEXT ARTICLE

More From BioPortfolio on "FDA clears Creo's Speedboat RS2 endoscopic device, CROMA platform"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...